Reset
Showing 20 of 70 academic articles

Methods in Molecular Biology

Julie Héroux, Ahmed M. Gharib • CRC Press eBooks (2008)

This chapter highlights the basic principles behind various molecular biology protocols, which should allow multidisciplinary imaging specialists to better understand the techniques. There is a vast diversity of methods in molecular biology...

OPENALEX other-oa DOI: https://doi.org/10.3109/9781420019957-3

Cold storage of human precision-cut lung slices in TiProtec preserves cellular composition and transcriptional responses and enables on-demand mechanistic studies

M. Camila Melo-Narvaez, Fee Gölitz, Eshita Jain, Janine Gote-Schniering et al. • Respiratory Research (2025)

Abstract Background Human precision-cut lung slices (hPCLS) are a unique platform for functional, mechanistic, and drug discovery studies in the field of respiratory research. However, tissue availability, generation, and cultivation time r...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12931-025-03132-w

Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening

Mourad A. M. Aboul-Soud, Alhusain J. Alzahrani, Amer Mahmoud • Cells (2021)

The discovery of induced pluripotent stem cells (iPSCs) has made an invaluable contribution to the field of regenerative medicine, paving way for identifying the true potential of human embryonic stem cells (ESCs). Since the controversy aro...

DOAJ Open Access (DOAJ) DOI: 10.3390/cells10092319

Natural Language Processing for EHR-Based Computational Phenotyping

Zexian Zeng, Yu Deng, Xiaoyu Li, Tristan Naumann et al. • IEEE Transactions on Computational Biology and Bioinformatics (2018)

This article reviews recent advances in applying natural language processing (NLP) to Electronic Health Records (EHRs) for computational phenotyping. NLP-based computational phenotyping has numerous applications including diagnosis categori...

OPENALEX Open Access DOI: https://doi.org/10.1109/tcbb.2018.2849968 PMC: 6388621

Artificial Intelligence in Healthcare: Advancing Innovation and Ethics to Foster Well-Being

Bayram B., Leventi N., Vodenicharova A., Lamprianidou A. et al. • Acta Medica Bulgarica (2026)

Artificial intelligence (AI) is reshaping healthcare by enhancing diagnostic precision, treatment personalization, and overall patient care. By leveraging technologies such as machine learning, deep learning, natural language processing, an...

DOAJ Open Access (DOAJ) DOI: 10.2478/amb-2026-0050

Overview of Artificial Neural Networks

Jinming Zou, Yi Han, Sung‐Sau So • Methods in molecular biology (2008)

The artificial neural network (ANN), or simply neural network, is a machine learning method evolved from the idea of simulating the human brain. The data explosion in modem drug discovery research requires sophisticated analysis methods to ...

OPENALEX DOI: https://doi.org/10.1007/978-1-60327-101-1_2

Quantum Leap in Healthcare: A Comparative Analysis of AI/ML and Quantum Computing for Healthcare opportunities of the new era

salma mostafa ahmed helmy, Salsabil Amin, Abeer mahmoud, El-Sayed El-Horabty • International Journal of Intelligent Computing and Information Sciences (2026)

The healthcare sector is undergoing rapid transformation driven by advances in artificial intelligence and machine learning, with quantum computing emerging as the next major breakthrough. This paper presents a comparative analysis of class...

DOAJ Open Access (DOAJ) DOI: 10.21608/ijicis.2026.442636.1439

DVNDTA: a dual virtual node based heterogeneous interaction model for accurate prediction of drug-target affinity

Guoqiang Zhou, Ben Li, Weifeng Zhang, Shudi Bao et al. • BMC Bioinformatics (2026)

Abstract Efficient prediction of drug-target affinity (DTA) is crucial for accelerating drug discovery. Recently, deep learning approaches leveraging 3D complexes have shown strong potential for drug-target affinity prediction. However, mos...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12859-026-06481-5

A deep-reinforcement learning approach for optimizing homogeneous droplet routing in digital microfluidic biochips

Basudev Saha, Bidyut Das, Mukta Majumder • Nanotechnology and Precision Engineering (2023)

Over the past two decades, digital microfluidic biochips have been in much demand for safety-critical and biomedical applications and increasingly important in point-of-care analysis, drug discovery, and immunoassays, among other areas. How...

DOAJ Open Access (DOAJ) DOI: 10.1063/10.0017350

ACtriplet: An improved deep learning model for activity cliffs prediction by integrating triplet loss and pre-training

Xinxin Yu, Yimeng Wang, Long Chen, Weihua Li et al. • Journal of Pharmaceutical Analysis (2025)

Activity cliffs (ACs) are generally defined as pairs of similar compounds that only differ by a minor structural modification but exhibit a large difference in their binding affinity for a given target. ACs offer crucial insights that aid m...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.jpha.2025.101317

The rise of deep learning in drug discovery

Hongming Chen, Ola Engkvist, Yinhai Wang, Marcus Olivecrona et al. • Drug Discovery Today (2018)

Over the past decade, deep learning has achieved remarkable success in various artificial intelligence research areas. Evolved from the previous research on artificial neural networks, this technology has shown superior performance to other...

OPENALEX cc-by DOI: https://doi.org/10.1016/j.drudis.2018.01.039

Deep Learning in Drug Discovery

Erik Gawehn, Jan A. Hiss, Gisbert Schneider • Molecular Informatics (2015)

Artificial neural networks had their first heyday in molecular informatics and drug discovery approximately two decades ago. Currently, we are witnessing renewed interest in adapting advanced neural network architectures for pharmaceutical ...

OPENALEX DOI: https://doi.org/10.1002/minf.201501008

Applications of Deep Learning in Biomedicine

Polina Mamoshina, Armando S. Vieira, Eugene Lane, Alex A. Zhavoronkov • Molecular Pharmaceutics (2016)

Increases in throughput and installed base of biomedical research equipment led to a massive accumulation of -omics data known to be highly variable, high-dimensional, and sourced from multiple often incompatible data platforms. While this ...

OPENALEX DOI: https://doi.org/10.1021/acs.molpharmaceut.5b00982

Integrative multiomics analysis of platelet-related genes unveils molecular subtypes and prognostic signatures in acute myeloid leukemia

Fangmin Zhong, Fangyi Yao, Zihao Wang, Bo Huang et al. • npj Precision Oncology (2025)

Abstract Acute myeloid leukemia (AML) remains challenging due to molecular heterogeneity and limited prognostic models integrating tumor microenvironment dynamics. While thrombocytopenia correlates with poor outcomes, the roles of platelet-...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41698-025-01137-8

Machine learning in pain research

Jörn Lötsch, Alfred Ultsch • Pain (2017)

1. Introduction Pain and pain chronification are incompletely understood and unresolved medical problems that continue to have a high prevalence.14 It has been accepted that pain is a complex phenomenon.2,32,72 Contemporary methods of compu...

OPENALEX cc-by-nc-nd DOI: https://doi.org/10.1097/j.pain.0000000000001118 PMC: 5895117

Knowledge-transfer learning for prediction of matrix metalloprotease substrate-cleavage sites

Yanan Wang, Jiangning Song, Tatiana T. Marquez-Lago, André Leier et al. • Scientific Reports (2017)

Abstract Matrix Metalloproteases (MMPs) are an important family of proteases that play crucial roles in key cellular and disease processes. Therefore, MMPs constitute important targets for drug design, development and delivery. Advanced pro...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41598-017-06219-7

Prediction of Drug Targets for Specific Diseases Leveraging Gene Perturbation Data: A Machine Learning Approach

Kai Zhao, Yujia Shi, Hon-Cheong So • Pharmaceutics (2022)

Identification of the correct targets is a key element for successful drug development. However, there are limited approaches for predicting drug targets for specific diseases using omics data, and few have leveraged expression profiles fro...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14020234